Publication Listing for the MeSH term Cell Cycle. Found 43 abstracts
no paginationPrudnikova TY, Villamar-Cruz O, Rawat SJ, Cai KQ, Chernoff J. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells. Oncogene. 2016 Apr 28;35(17):2178-85. PMCID: PMC5125076 |
Chakraborty AK, Mehra R, Digiovanna MP. Co-targeting ER and HER family receptors induces apoptosis in HER2-normal or overexpressing breast cancer models. Anticancer research. 2015 Mar;35(3):1243-50. |
Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell. 2012 Jul;23(14):2658-70. PMCID: PMC3395655 |
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS One. 2012 Oct;7(10):e47086. PMCID: 3467214 |
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Targeting EGFR resistance networks in head and neck cancer. Cell Signal. 2009 Aug;21(8):1255-68. PMCID: PMC2770888 |
Enders GH. Expanded roles for Chk1 in genome maintenance. The Journal of biological chemistry. 2008 Jun 27;283(26):17749-52. PMCID: PMC2440615 |
Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ, Muschel RJ. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res. 2008 May 15;68(10):3724-32. |
Plotnikova OV, Golemis EA, Pugacheva EN. Cell cycle-dependent ciliogenesis and cancer. Cancer Res. 2008 Apr;68(7):2058-61. PMCID: PMC2546565 |
Ariazi EA, Leitao A, Oprea TI, Chen B, Louis T, Bertucci AM, Sharma CG, Gill SD, Kim HR, Shupp HA, Pyle JR, Madrack A, Donato AL, Cheng D, Paige JR, Jordan VC. Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen. Mol Cancer Ther. 2007 Nov;6(11):2817-27. |
Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007 Mar;27(6):2343-58. |
Pugacheva EN, Roegiers F, Golemis EA. Interdependence of cell attachment and cell cycle signaling. Current opinion in cell biology. 2006 Oct;18(5):507-15. |
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental cell. 2005 Jan;8(1):19-30. |
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9. |
He J, Xu J, Xu XX, Hall RA. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. Oncogene. 2003 Jul 17;22(29):4524-30. |
Chaturvedi P, Sudakin V, Bobiak ML, Fisher PW, Mattern MR, Jablonski SA, Hurle MR, Zhu Y, Yen TJ, Zhou BB. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res. 2002 Mar 15;62(6):1797-801. |
Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. The Journal of biological chemistry. 2002 Feb;277(5):3247-57. |
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol. 2002 Nov;22(22):7831-41. |
Khare L, Astrinidis A, Senapedis W, Adams PD, Henske EP. Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells. J Med Genet. 2002 Sep;39(9):676-80. |
Knudson AG. Cancer genetics. Am J Med Genet. 2002 Jul 22;111(1):96-102. |
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28. |
MeSH cloud from publications including the MeSH term Cell Cycle
Cell Cycle
genetics
metabolism
physiology
Apoptosis
Human
Female
US Gov't Support-PHS
Cell Line
Protein p53
Amino Acid Sequence
Cultured Tumor Cells
Signal Transduction
Non-US Gov't Support
chemistry
drug effects
Mitosis
Cell Cycle Proteins
Tumor Cell Line
Mice
Cell Proliferation
Molecular Sequence Data
antagonists & inhibitors
Transcription Factors
Non-Histone Chromosomal Proteins
DNA Damage
Neoplasm Proteins
Small Interfering RNA
ph [Physiology]
pathology
Neoplastic Gene Expression Regulation
Neoplasms
pharmacology
Transfection
Phosphorylation
me [Metabolism]
Mutation
Mitotic Spindle Apparatus
0 (Transcription Factors)
Cytokinesis
Proteins
Rats
Proto-Oncogene Proteins c-bcl-2
de [Drug Effects]
Biological Models
Antineoplastic Agents
Histones
Animal
Tumor Suppressor Genes
Paclitaxel
Cilia
Recombinant Fusion Proteins
DNA-Binding Proteins
Molecular Models
Reverse Transcriptase Polymerase Chain Reaction
0 (Neoplasm Proteins)
aa [Analogs & Derivatives]
Hela Cells
Genetic Transcription
Protein Binding
Nuclear Proteins
Centrosome
Ovarian Neoplasms
Breast Neoplasms
pd [Pharmacology]
Gene Expression Regulation
Repressor Proteins
DNA Repair
drug therapy
Chromatin
Cyclins
Cell Aging
RNA Interference
Heterochromatin
bi [Biosynthesis]
Estrogen Antagonists
trastuzumab (Herceptin)
Alkylating) 0 (Antineoplastic Agents
Cytoplasmic and Nuclear) 0 (Receptors
Phosphoprotein Phosphatase
Enzyme Activation
0 (Cyclins)
0 (Nuclear Proteins)
0 (Repressor Proteins)
Okadaic Acid
Androgens
fulvestrant (Faslodex)
Adult
169590-42-5 (celecoxib)
epidemiology
Western Blotting
684-93-5 (Methylnitrosourea)
Genotype
CDC2 Protein Kinase
33069-62-4 (Paclitaxel)
Fibroblasts
23214-92-8 (Doxorubicin)
Cyclin-Dependent Kinases
mammalian) 0 (MLH1 protein
Androstadienes
4342-03-4 (Dacarbazine)
Cell Cycle Checkpoints
Calmodulin
Non-US Gov't Research Support
Hydroxylation
Peptidylprolyl Isomerase
Dosage Compensation (Genetics)
0 (macroH2A histone)
Conserved Sequence
Gamma Rays
protein HP-1)
Carcinogens
Immunohistochemistry
35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine)
Experimental Mammary Neoplasms
0 (Fluorenes)
Dacarbazine
ai [Antagonists & Inhibitors]
estrogen receptor (ER)
DNA Repair Enzymes
Ionizing Radiation
Dinoprostone
deficiency
Cell Adhesion
0 (15-deoxyprostaglandin J2)
Oncogenes
EC 3-6-1-3 (Adenosinetriphosphatase)
Drug Interactions
Carrier Proteins
G2 Phase
Calcineurin
ras Proteins
therapy
Sprague-Dawley Rats
biosynthesis
Phosphoproteins
human) 0 (ASF1A protein
Cultured Cells
EC 6-5-1 (DNA Repair Enzymes)
Stress
Isoenzymes
ErbB-2 Receptor
methods
Adenosinetriphosphatase
Epidermal Growth Factor Receptor
0 (Recombinant Fusion Proteins)
Adenocarcinoma
0 (Isoenzymes)
Her2
Cell Division